PPAR signaling pathway may be an important predictor of breast cancer response to neoadjuvant chemotherapy.
Chen YZ, Xue JY, Chen CM, Yang BL, Xu QH, Wu F, Liu F, Ye X, Meng X, Liu GY, Shen ZZ, Shao ZM, Wu J.
Chen YZ, et al. Among authors: liu gy, liu f.
Cancer Chemother Pharmacol. 2012 Nov;70(5):637-44. doi: 10.1007/s00280-012-1949-0. Epub 2012 Aug 19.
Cancer Chemother Pharmacol. 2012.
PMID: 22903535
Clinical Trial.